John Pappajohn is Director at CANCER GENETICS, INC (CGIX). They have made 68 open-market trades across 12 companies since 2005, most recently 2019-07-16.
CIK 0001349929
66 open-market purchases totalling $11.0M since 2005, against 2 sales. Across 33 scored buys the stock is down 4.2% at ninety days, and 6.6 points behind the S&P over the same stretch.
33 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 39% | 55% | 55% |
| Avg Move | -8.1% | -1.8% | -4.2% |
| Alpha | -7.1% | -2.7% | -6.6% |
| Scored | 33 | 33 | 33 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYND | BUY | 2019-05-23 | 2019-05-23 | $1.25 | $250K | -7.4% | -3.0% | -1.9% |
| MYND | BUY | 2019-03-14 | 2019-03-14 | $1.68 | $168K | -18.0% | -8.6% | -20.0% |
| CGIX | BUY | 2019-01-31 | 2019-02-01 | $0.23 | $230K | -3.7% | -0.7% | -15.8% |
| CGIX | BUY | 2019-01-14 | 2019-01-16 | $0.23 | $230K | -7.2% | -7.5% | -7.9% |
| MYND | BUY | 2018-08-28 | 2018-08-28 | $1.63 | $163K | -3.4% | -1.5% | -59.7% |
| MYND | BUY | 2018-01-05 | 2018-01-08 | $3.44 | $34K | +11.4% | +4.1% | +4.2% |
| CGIX | BUY | 2017-12-08 | 2017-12-11 | $1.86 | $279K | +5.3% | +5.3% | +5.3% |
| CGIX | BUY | 2017-08-17 | 2017-08-18 | $3.28 | $66K | +1.5% | -7.5% | -22.4% |
| CGIX | BUY | 2017-08-17 | 2017-08-18 | $3.25 | $280K | +1.5% | -7.5% | -22.4% |
| MYND | BUY | 2017-08-09 | 2017-08-10 | $3.34 | $17K | +15.2% | +6.8% | +9.4% |
| MYND | BUY | 2017-08-02 | 2017-08-03 | $3.65 | $18K | +15.2% | +6.8% | +6.2% |
| MYND | BUY | 2017-07-25 | 2017-07-26 | $4.00 | $20K | +15.2% | +6.8% | +7.2% |
| MYND | BUY | 2017-07-21 | 2017-07-25 | $4.25 | $43K | +15.2% | +6.8% | +7.3% |
| MYND | BUY | 2017-07-17 | 2017-07-19 | $4.47 | $45K | +15.2% | +6.8% | +18.1% |
| CGIX | BUY | 2017-06-12 | 2017-06-12 | $3.75 | $375K | -1.3% | +3.9% | -14.3% |
| CGIX | BUY | 2017-05-16 | 2017-05-17 | $3.80 | $73K | +6.8% | -1.4% | -16.2% |
| MYAN | BUY | 2017-04-03 | 2017-04-06 | $6.46 | $64K | N/A | N/A | N/A |
| HH | BUY | 2017-03-09 | 2017-04-21 | $0.74 | $118K | N/A | N/A | N/A |
| CGIX | BUY | 2016-11-28 | 2016-11-29 | $1.45 | $145K | -6.1% | -15.2% | +45.5% |
| CGIX | BUY | 2016-11-14 | 2016-11-16 | $1.48 | $46K | -3.0% | -15.2% | +36.4% |
| MYAN | BUY | 2016-10-20 | 2016-10-24 | $8.50 | $2K | N/A | N/A | N/A |
| MYAN | BUY | 2016-10-17 | 2016-10-19 | $8.00 | $8K | N/A | N/A | N/A |
| MYAN | BUY | 2016-10-12 | 2016-10-14 | $7.50 | $120 | N/A | N/A | N/A |
| MYAN | BUY | 2016-10-10 | 2016-10-12 | $6.45 | $12K | N/A | N/A | N/A |
| CGIX | BUY | 2016-08-16 | 2016-08-17 | $2.29 | $206K | -6.6% | -28.5% | -33.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| GNOW |
| 6,278,672 |
| — |
| HAQ | 1,142,000 | — |
| MYAN | 506,290 | — |
| PrivateUnlisted | 1,132,925 | — |
| PATY | 6,715,521 | — |
| PCES | 2,331,740 | — |
| SCIE.OB | 547,142 | — |
| ACSH.OB | 4,164,962 | — |
| SPECTR#2 | 3,947,142 | — |
| ALLI | 627,564 | — |
| ANCI | 2,289,398 | — |
| CHMH | 2,497,846 | — |
| Total | $26.1M |
Shares reported on the most recent Form 4, priced at the 2019-07-18 close. 15 holdings could not be priced and are excluded from the total.